AI Bias Analysis
4 models · Takes ~15 seconds
Johnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors.
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- Richard Lokudu, MD, the medical director of Mongbwalu General Referral Hospital, has received barely any compensation for his work on the front line of one of Congo's deadliest Ebola virus outbreaks. Lokudu and several of his...
(MedPage Today) -- Fewer toddlers developed egg allergies after guidelines changed to recommend introducing egg products in infancy, large population-based studies from Australia showed. As the proportion of infants introduced to egg by 6 months...
The biggest U.S. health insurer is changing how it pays for lactation counseling, and it could cut payment for many providers.
Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news
